• $12.7M
    Market Cap
  • -99.53%
    1-Year Change
  • Pharmaceutical Retailers
    Industry
Annual
Quarterly
12/31/2025
Income Statement
Total Operating Revenue
399.4M
N/A
Cost of Revenue
347.6M
N/A
Gross Profit
52.3M
N/A
Sales and Marketing Expense
96.2M
N/A
Research and Development Expense
-12.9M
N/A
Depreciation and Amortization Expense
149,307
N/A
Total Operating Expenses
170.9M
N/A
Operating Profit
-118.6M
N/A
Interest Income
496,122
N/A
Interest Expense
-8.1M
N/A
Interest Income and Expense and Net
-7.6M
N/A
Total Nonoperating Income and Expense
-12.3M
N/A
Income before Taxes
-130.9M
N/A
Income Taxes
375
N/A
Extraordinary Items
N/A
N/A
Net Income
-130.9M
N/A
Net Income from Continuing Operations Applicable to Common
-212.6M
N/A
Basic EPS and Net Income
-21.96
N/A
Diluted EPS and Net Income
-21.96
N/A
Basic Weighted Average Shares
9.7M
N/A
Diluted Weighted Average Shares
9.7M
N/A
Balance Sheet
Cash and Cash Equivalents
8.4M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.4M
N/A
Total Current Assets
105.0M
N/A
Accumulated Depreciation
10.7M
N/A
Property and Plant and Equipment and Net
1.2M
N/A
Total Long-Term Assets
2.6M
N/A
Total Assets
107.6M
N/A
Income Taxes Payable
658,492
N/A
Total Short-Term Debt
68.2M
N/A
Total Current Liabilities
218.2M
N/A
Total Long-Term Debt
13.0M
N/A
Total Long-Term Liabilities
370.7M
N/A
Total Liabilities
588.9M
N/A
Retained Earnings
-2.5B
N/A
Total Stockholders Equity
-454.0M
N/A
Total Shares Outstanding
21.1M
N/A
Cash Flow
Cash from Operating Activities
-148.5M
N/A
Capital Expenditures
1.0M
N/A
Cash from Investing Activities
-1.6M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
153.9M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow